Literature DB >> 23027694

Malignant osseous tumors of the pediatric spine.

Han Jo Kim1, Alexander S McLawhorn, Matthew J Goldstein, Patrick J Boland.   

Abstract

In the pediatric population, malignant osseous tumors of the spine include osteosarcoma, Ewing sarcoma, lymphoma, and metastatic neuroblastoma. Although these tumors are rare, prompt diagnosis and recognition are critical to the overall prognosis. Improved understanding of the natural history of spine deformity, combined with advances in imaging, surgical technology, radiation therapy, and chemotherapeutic regimens, has improved survival rates and decreased rates of local recurrence-especially recurrence of low-grade lesions. Prognosis for patients with high-grade lesions with distant metastasis on presentation remains exceedingly poor. Recognition of these spine tumors and prompt referral to a tertiary care center that specializes in oncology can optimize patient outcomes.

Entities:  

Mesh:

Year:  2012        PMID: 23027694     DOI: 10.5435/JAAOS-20-10-646

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  4 in total

Review 1.  Pediatric back pain-Diagnostic algorithm.

Authors:  Y Kentar; M Schwarze; W Pepke; M Schiltenwolf; M Akbar
Journal:  Orthopade       Date:  2021-11-12       Impact factor: 1.087

2.  Primary malignant bone tumours of spine and pelvis in children.

Authors:  Ilkka J Helenius; Andreas H Krieg
Journal:  J Child Orthop       Date:  2021-08-20       Impact factor: 1.548

3.  Long-term survival following resection of extracompartmental osteosarcoma of the spine - A case report and literature review.

Authors:  Suresh S Pillai
Journal:  Surg Neurol Int       Date:  2021-11-02

4.  Spinal giant cell-rich osteosarcoma-diagnostic dilemma and treatment strategy: A case report.

Authors:  Chen-Sheng Tseng; Chia-En Wong; Chi-Chen Huang; Hao-Hsiang Hsu; Jung-Shun Lee; Po-Hsuan Lee
Journal:  World J Clin Cases       Date:  2022-07-26       Impact factor: 1.534

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.